Finance Advisory Committee

The Mission:

To build relationships between and among financial professionals throughout the BioNJ Membership and the NJ life sciences ecosystem to foster educational and professional community,  information sharing and peer to peer collaboration to facilitate scientific and medical advancement through financial stewardship.

The Vision:

A highly networked ecosystem and platform for CFO professionals to leverage best practices and experience to optimize funding accessibility and opportunities for life science innovation to drive advancements in patient care.

Committee Members

Chip Baird, CFO, Amicus Therapeutics, Inc.
Rachael Bushey, Partner, Pepper Hamilton
Gary Gaglione, CFO, VP of Finance, Matinas BioPharma
Thomas Giannone, Principal, Avison Young
Karen Krumeich, CFO, Soligenix
Brian Lenz, Vice President and Chief Financial Officer, ADMA Biologics, Inc.
Michael Losch, CFO, Signum Biosciences
Scott Megaffin, President, Churchill Pharmaceuticals
Anthony Pagano, SVP – Global Finance, Genmab
John Pennett, Partner, EisnerAmper
Chris Pierce, Partner, PricewaterhouseCoopers LLP
Tony Torrington, Partner, EY
Joel Wagner, Senior Manager, Assurance Svcs, EY
Yaron Werber, MD, CBO & CFO, Ovid Therapeutics